Journal article
Ethnicity/Race, Use of Pharmacotherapy, Scope of Physician-Ordered Cholesterol Screening, and Provision of Diet/Nutrition or Exercise Counseling during US Office-Based Visits by Patients with Hyperlipidemia
American journal of cardiovascular drugs : drugs, devices, and other interventions, Vol.10(2), pp.105-108
04/2010
Handle:
https://hdl.handle.net/2376/106535
PMID: 20334447
Abstract
Elevation of serum cholesterol, or hyperlipidemia, is recognized as one of the major modifiable risk factors in the development of atherosclerosis and cardiovascular disease. On a US population basis, there has been a downward trend in total- and LDL-cholesterol levels, and an increase in cholesterol screening. Nevertheless, previous research suggests that there remain racial/ethnic disparities in the access to and quality of care for hyperlipidemia.The aim of this study was to examine the extent of racial/ethnic disparities in the provision of pharmacotherapy, cholesterol screening and diet/nutrition or exercise counseling during US office-based physician-patient encounters (visits) by patients with hyperlipidemia.We examined data from the 2005 US National Ambulatory Medical Care Survey for office-based visits for hyperlipidemia for patients aged ≥20 years in terms of prescribing for hyperlipidemia, and the ordering/provision of cholesterol testing, diet/nutrition counseling, and exercise counseling.Use of pharmacotherapy for hyperlipidemia varied by ethnicity/race (χ2, p<0.05). Physician-ordered/provided cholesterol screening occurred in 44.2% of all office-based visits; 46.5% for Whites, 35.4% for Blacks, and 30.3% for Hispanics (χ2, p< 0.05). Diet/nutrition counseling was ordered/provided in 39.7% of office-based visits; 40.4% for Whites, 32.6% for Blacks, and 39.0% for Hispanics (χ2, p<0.05). Exercise counseling was ordered/provided in 32.1% of office-based visits; 32.7% for Whites, 27.2% for Blacks, and 30.6% for Hispanics (χ2, p<0.05).These findings reveal a disparity in use of pharmacotherapy for hyperlipidemia, physicianordered/provided cholesterol screening, diet/nutrition counseling, and exercise counseling by ethnicity/race. Further research is required to discern, in greater detail, reasons for the observed differences reported, and to ensure equitable access to established standards of care.
Metrics
10 Record Views
Details
- Title
- Ethnicity/Race, Use of Pharmacotherapy, Scope of Physician-Ordered Cholesterol Screening, and Provision of Diet/Nutrition or Exercise Counseling during US Office-Based Visits by Patients with Hyperlipidemia
- Creators
- Megan Willson - Department of Pharmacotherapy, College of Pharmacy Washington State University PO Box 1495 Spokane WA 99210 USAJoshua Neumiller - Department of Pharmacotherapy, College of Pharmacy Washington State University PO Box 1495 Spokane WA 99210 USADavid Sclar - Department of Health Policy and Administration, College of Pharmacy Washington State University Pullman Washington USALinda Robison - Department of Health Policy and Administration, College of Pharmacy Washington State University Pullman Washington USATracy Skaer - Department of Health Policy and Administration, College of Pharmacy Washington State University Pullman Washington USA
- Publication Details
- American journal of cardiovascular drugs : drugs, devices, and other interventions, Vol.10(2), pp.105-108
- Academic Unit
- Pharmacotherapy, Department of
- Publisher
- Springer International Publishing; Cham
- Identifiers
- 99900546975001842
- Language
- English
- Resource Type
- Journal article